Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation
NCT05567536 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5530
Last updated 2022-10-05
Summary
This is an retrospective extended study of a randomized clinical trial (The HOST-EXAM trial ClinicalTrials.gov Identifier: NCT02044250).
Investigators will perform a retrospective analysis of all participants enrolled in this trial will be performed, until the longest follow-up duration.
Conditions
- Coronary Artery Disease
- Atheroscleroses, Coronary
Interventions
- DRUG
-
Antiplatelet Agents
Patients who received a single antiplatelet agent will be analyzed according to the prescribed antiplatelet agent
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-01
- Primary Completion
- 2022-10-01
- Completion
- 2028-12-31
- FDA Drug
- Yes
More Related Trials
-
Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin
NCT01763749 ·Status: COMPLETED ·Phase: PHASE4
-
Anticoagulation in Stent Intervention
NCT01141153 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of Clopidogrel
NCT01503658 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial
NCT01496261 ·Status: COMPLETED ·Phase: PHASE1
-
Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation
NCT00590174 ·Status: COMPLETED ·Phase: PHASE4
-
Association of Clopidogrel Therapy and Stent Thrombosis
NCT00484926 ·Status: COMPLETED ·Phase: PHASE4
-
SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3
NCT04418479 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
NCT00404781 ·Status: COMPLETED ·Phase: PHASE4
-
The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease
NCT03577652 ·Status: COMPLETED ·Phase: NA
-
Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism
NCT00891670 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Clopidogrel Loading and Risk of PCI
NCT00457236 ·Status: UNKNOWN
-
Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial
NCT03431142 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
NCT02319941 ·Status: COMPLETED ·Phase: PHASE2
-
Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition
NCT01582217 ·Status: COMPLETED
-
The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol
NCT00620646 ·Status: COMPLETED ·Phase: NA
-
Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
NCT00915733 ·Status: COMPLETED ·Phase: PHASE4
-
Resistance to Antithrombotic Therapy
NCT00858715 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration
NCT01526122 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination
NCT01663038 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery
NCT01146301 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents
NCT00947843 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial
NCT03947229 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
NCT00405717 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES
NCT05770674 ·Status: RECRUITING ·Phase: NA
-
Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)
NCT01186146 ·Status: COMPLETED ·Phase: PHASE4